Please login to the form below

Not currently logged in
Email:
Password:

AllTrials

This page shows the latest AllTrials news and features for those working in and with pharma, biotech and healthcare.

Is competition the enemy of progress and collaboration the ally of success?

Is competition the enemy of progress and collaboration the ally of success?

Movements such as the AllTrials campaign and subsequent regulatory requirements to publish all clinical trial data in recent years have shown just how willing the pharma industry is to be more

Latest news

  • UCB launches online clinical trial tool UCB launches online clinical trial tool

    Although UCB signed up to a clinical trial data sharing portal in 2014 it only received a mid-table ranking from an AllTrials audit last year.

  • AllTrials tracker site names clinical trial non-reporters AllTrials tracker site names clinical trial non-reporters

    Organisations that fail to report the results of their clinical trials are to be named on a new website set up by the AllTrials campaign group. ... A letter from AllTrials campaigners Ben Goldacre and Síle Lane to FDA Commissioner Scott Gottlieb

  • Shire says all its studies will publish in open access journals Shire says all its studies will publish in open access journals

    Last year for example, an audit of 42 top manufacturers from the EU, US and Japan by the trial transparency pressure group AllTrials found massive variations between companies when it came

  • The state of trust The state of trust

    However, it’s really important we’re honest around this,” he admitted. Thoughts on industry honesty then naturally sparked questions centring on AllTrials. ... We have been in conversation with AllTrials to make sure that transparency is available

  • Audit exposes gaps in pharma's promises on trial transparency Audit exposes gaps in pharma's promises on trial transparency

    The researchers also found that company policies are ‘often vague, ambiguously worded, internally contradictory or difficult to interpret’, according to AllTrials. ... AllTrials says it is now able to identify unreported trials and ‘over the next

More from news
Approximately 23 fully matching, plus 31 partially matching documents found.

Latest Intelligence

  • LEO: Patients benefit from transparency LEO: Patients benefit from transparency

    Paving the way for openness in pharma. Pharma has still got some way to go to improve industry-wide publication of clinical trial results, as the AllTrials audit shows in stark ... One of those is LEO Pharma. Ranked second-best overall for its approach,

  • Could EFPIA's new code boost pharma's reputation? Could EFPIA's new code boost pharma's reputation?

    We've already done a lot in the transparency space,” McDonough said, adding: “In 2013, we were the first [and currently, the only] pharma firm to sign up to the AllTrials ... But after they announced their decision to do this last year - just as with

  • Interview: Beate Wieseler, IQWIG Interview: Beate Wieseler, IQWIG

    for greater transparency of clinical trial detail, becoming one of the first major groups to sign up to the AllTrials campaign led by Dr Ben Goldacre. ... And therefore we were happy to support the AllTrials campaign.”. As for Dr Wieseler's views on

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hanson Zandi

Hanson Zandi is a Creative and Digital Healthcare Agency. We combine 30 years’ experience with the enthusiasm of a start-up...

Latest intelligence

How do companies prepare for reimbursement?
Valid Insight explore how to optimise your market access strategy during new product development, how to address payer concerns and prepare for reimbursement....
EHR clinical trials
Integrating electronic health records into clinical trials
How organisations are working to realise the research potential of EHRs...
Mike Elliott Gilead
Keeping up the fight against HIV and using the lessons to tackle other threats
Danny Buckland interviews Gilead’s Mike Elliott...

Infographics